Positron emission tomography (pet) methodology for small animals and its application in radiopharmaceutical preclinical investigation
- 25 November 1998
- journal article
- review article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 25 (8) , 729-732
- https://doi.org/10.1016/s0969-8051(98)00055-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Three-dimensional performance of a small-diameter positron emission tomographPhysics in Medicine & Biology, 1997
- Evaluation in rat of RS-79948-197 as a potential PET ligand for central α2-adrenoceptorsEuropean Journal of Pharmacology, 1996
- The advantage of using positron emission tomography in drug researchTrends in Neurosciences, 1996
- Development of central 5-HT2A receptor radioligands for PET: Comparison of [3H]RP 62203 and [3H]SR 46349B kinetics in rat brainNuclear Medicine and Biology, 1996
- Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporterNuclear Medicine and Biology, 1996
- Specific in vivo binding in the rat brain of [18F]RP 62203: A selective 5-HT2A receptor radioligand for positron emission tomographyNuclear Medicine and Biology, 1996
- Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them?European Journal of Nuclear Medicine and Molecular Imaging, 1996
- Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55Brain Research, 1995
- The design and physical characteristics of a small animal positron emission tomographPhysics in Medicine & Biology, 1995
- Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brainEuropean Journal of Pharmacology, 1994